who should not use glp-1 Safety: Shouldn't These Medications Should GLP-1 Drugs Be Over

Each serving delivers 500 million active cultures (AFU) of targeted strains to provide gentle, effective metabolic support without overstimulating the gut

THURSDAY, June 25, 2026 (HealthDay News) As the use of GLP-1 medications for weight loss surges, so do calls to U.S

Most people taking a 1,250 version wont even know they need to tell their doctor

PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care, Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity. Key Highlights: Digbi GLP-Fit uses the science of precision biology to identify the best treatment path for obesity for an individual with 87% accuracy, which may include 1) only precision nutrition, 2) a combination of precision nutrition and lower-cost drugs like Metformin, or 3) a combination of precision nutrition and GLP-1 medications

Real-world semaglutide and tirzepatide results from Glapp tracking app.

How to Take - Take 2 capsules per day, 15 to 30 minutes before meals